$271Million | No. of Holdings #9
Foresite Capital Management V, LLC Performance
| Ticker | $ Bought |
|---|---|
| eikon therapeutics, inc. | 13,954,800 |
| pharvaris n.v. | 5,484,030 |
| nurix therapeutics, inc. | 4,107,500 |
| Ticker | % Inc. |
|---|---|
| hims & hers health, inc. | 170 |
| disc medicine, inc. | 25.08 |
| alumis inc. | 2.04 |
| Ticker | % Reduced |
|---|---|
| maze therapeutics, inc. | -69.98 |
| Ticker | $ Sold |
|---|---|
| natera, inc. | -15,430,600 |
Foresite Capital Management V, LLC has about 89.3% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 89.3 |
| Consumer Defensive | 5.7 |
| Healthcare | 5 |
Foresite Capital Management V, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 89.3 |
| MID-CAP | 5.7 |
| SMALL-CAP | 5 |
About 10.7% of the stocks held by Foresite Capital Management V, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 89.3 |
| RUSSELL 2000 | 10.7 |
| Top 5 Winners (%) | % | |
|---|---|---|
alumis inc. | 122.9 % | |
cg oncology, inc. | 63.0 % | |
| Top 5 Winners ($) | $ | |
|---|---|---|
alumis inc. | 71.6 M | |
cg oncology, inc. | 26.3 M | |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Foresite Capital Management V, LLC has 9 stocks in it's portfolio. HIMS proved to be the most loss making stock for the portfolio. was the most profitable stock for Foresite Capital Management V, LLC last quarter.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
Hims & Hers Health, Inc. Foresite Capital Management V, LLC's holding in Hims & Hers Health, Inc. over time | 5.66% | 738,151 | $15.32M 5.66% | 170.24%increased 170.24 percentadded | |
Lyell Immunopharma, Inc. Foresite Capital Management V, LLC's holding in Lyell Immunopharma, Inc. over time | 3.53% | 477,078 | $9.57M 3.53% | 0%unchanged 0 percentunchanged | |
Nurix Therapeutics, Inc. Foresite Capital Management V, LLC's holding in Nurix Therapeutics, Inc. over time | 1.52% | 265,000 | $4.11M 1.52% | Newnew position | |
Natera, Inc. Natera, Inc.NTRA Foresite Capital Management V, LLC's holding in Natera, Inc. over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
PHVS Pharvaris N.V.Pharvaris N.V.PHVS | 2.02% | 194,125 | $5.48M 2.02% | Newnew position | |
Com Alumis Inc.Alumis Inc. | 47.94% | 5,897,000 | $129.91M 47.94% | 2.04%increased 2.04 percentadded | |
Com Cg Oncology, Inc.Cg Oncology, Inc. | 25.08% | 1,004,050 | $67.95M 25.08% | 0%unchanged 0 percentunchanged | |
Com Disc Medicine, Inc.Disc Medicine, Inc. | 8.83% | 374,069 | $23.92M 8.83% | 25.08%increased 25.08 percentadded | |
Com Eikon Therapeutics, Inc.Eikon Therapeutics, Inc. | 5.15% | 1,318,980 | $13.95M 5.15% | Newnew position | |
Com Maze Therapeutics, Inc.Maze Therapeutics, Inc. | 0.28% | 25,905 | $773.3K 0.28% | 69.98%decreased 69.98 percentreduced | |